Intellia Therapeutics Stock Forward View - Accumulation Distribution
| NTLA Stock | USD 12.28 1.19 10.73% |
Intellia Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Intellia Therapeutics stock prices and determine the direction of Intellia Therapeutics's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Intellia Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time the rsi of Intellia Therapeutics' share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.95) | EPS Estimate Current Year (4.00) | EPS Estimate Next Year (3.60) | Wall Street Target Price 23.8571 | EPS Estimate Current Quarter (0.98) |
Using Intellia Therapeutics hype-based prediction, you can estimate the value of Intellia Therapeutics from the perspective of Intellia Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Intellia Therapeutics using Intellia Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Intellia using crowd psychology based on the activity and movement of Intellia Therapeutics' stock price.
Intellia Therapeutics Short Interest
A significant increase or decrease in Intellia Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards Intellia. Short interest can provide insight into the potential direction of Intellia Therapeutics stock and how bullish or bearish investors feel about the market overall.
200 Day MA 11.8614 | Short Percent 0.4122 | Short Ratio 9.88 | Shares Short Prior Month 41.6 M | 50 Day MA 10.5828 |
Intellia Relative Strength Index
Intellia Therapeutics Hype to Price Pattern
Investor biases related to Intellia Therapeutics' public news can be used to forecast risks associated with an investment in Intellia. The trend in average sentiment can be used to explain how an investor holding Intellia can time the market purely based on public headlines and social activities around Intellia Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Intellia Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Intellia Therapeutics.
Intellia Therapeutics Implied Volatility | 1.58 |
Intellia Therapeutics' implied volatility exposes the market's sentiment of Intellia Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Intellia Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Intellia Therapeutics stock will not fluctuate a lot when Intellia Therapeutics' options are near their expiration.
Intellia Therapeutics after-hype prediction price | USD 13.22 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Intellia Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Intellia contract
Based on the Rule 16, the options market is currently suggesting that Intellia Therapeutics will have an average daily up or down price movement of about 0.0988% per day over the life of the 2026-04-17 option contract. With Intellia Therapeutics trading at USD 12.28, that is roughly USD 0.0121 . If you think that the market is fully incorporating Intellia Therapeutics' daily price movement you should consider acquiring Intellia Therapeutics options at the current volatility level of 1.58%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Intellia Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Intellia Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Intellia Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Intellia Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Intellia Therapeutics' open interest, investors have to compare it to Intellia Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Intellia Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Intellia. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Intellia Therapeutics Additional Predictive Modules
Most predictive techniques to examine Intellia price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Intellia using various technical indicators. When you analyze Intellia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 604274.0 | 377488.0 |
| Check Intellia Therapeutics Volatility | Backtest Intellia Therapeutics | Information Ratio |
Intellia Therapeutics Trading Date Momentum
| On February 06 2026 Intellia Therapeutics was traded for 12.28 at the closing time. The top price for the day was 12.33 and the lowest listed price was 11.32 . The trading volume for the day was 4.6 M. The trading history from February 6, 2026 did not cause price change. The trading delta at closing time against the current closing price is 7.82% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Intellia Therapeutics to competition |
Other Forecasting Options for Intellia Therapeutics
For every potential investor in Intellia, whether a beginner or expert, Intellia Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Intellia Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Intellia. Basic forecasting techniques help filter out the noise by identifying Intellia Therapeutics' price trends.Intellia Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Intellia Therapeutics stock to make a market-neutral strategy. Peer analysis of Intellia Therapeutics could also be used in its relative valuation, which is a method of valuing Intellia Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Intellia Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Intellia Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Intellia Therapeutics shares will generate the highest return on investment. By undertsting and applying Intellia Therapeutics stock market strength indicators, traders can identify Intellia Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 377488.0 | |||
| Daily Balance Of Power | 1.178218 | |||
| Rate Of Daily Change | 1.11 | |||
| Day Median Price | 11.83 | |||
| Day Typical Price | 11.98 | |||
| Price Action Indicator | 1.05 | |||
| Period Momentum Indicator | 1.19 |
Intellia Therapeutics Risk Indicators
The analysis of Intellia Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Intellia Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting intellia stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.31 | |||
| Semi Deviation | 6.05 | |||
| Standard Deviation | 5.93 | |||
| Variance | 35.12 | |||
| Downside Variance | 37.88 | |||
| Semi Variance | 36.65 | |||
| Expected Short fall | (4.53) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Intellia Therapeutics
The number of cover stories for Intellia Therapeutics depends on current market conditions and Intellia Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Intellia Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Intellia Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Intellia Therapeutics Short Properties
Intellia Therapeutics' future price predictability will typically decrease when Intellia Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Intellia Therapeutics often depends not only on the future outlook of the potential Intellia Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Intellia Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 98.8 M | |
| Cash And Short Term Investments | 601.5 M |
Check out Historical Fundamental Analysis of Intellia Therapeutics to cross-verify your projections. For information on how to trade Intellia Stock refer to our How to Trade Intellia Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intellia Therapeutics. Anticipated expansion of Intellia directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Intellia Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (4.25) | Revenue Per Share | Quarterly Revenue Growth 0.513 | Return On Assets | Return On Equity |
The market value of Intellia Therapeutics is measured differently than its book value, which is the value of Intellia that is recorded on the company's balance sheet. Investors also form their own opinion of Intellia Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Intellia Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intellia Therapeutics' market value can be influenced by many factors that don't directly affect Intellia Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Intellia Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Intellia Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Intellia Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.